Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Himanshu Mishra casting director is all set to bring out Two Celebrities: Pratik Sehajpal and Aditi Budhathoki in His New Upcoming Song Business
  • Zero Booking Fee Event Ticketing Platform disrupting Event Management Software Industry Business
  • Satish Sanpal on Why Dubai Real Estate Is Entering a More Mature Phase Business
  • Why is BYO better than OYO & Fabhotels? Business
  • The Sicilian Games 2023: A fiesta of sports, carnival, and bonding Press Release
  • Mamta Parvez Khan Shines on the Red Carpet at the 78th Cannes Film Festival Lifestyle
  • “Sound Of Success” Initiative by – CritiCare Asia group of Hospitals Business
  • Symphony Ltd Launches Hair Fall Control Geysers for Healthier Hair and Skin Business

Gujarat Kidney and Super Speciality raises over Rs 100 crore from 10 anchor investors ahead of IPO

Posted on December 23, 2025 By

The company’s IPO will open on December 22 and close on December 24, 2025

New Delhi [India], December 23: Multispecialty hospital chain, Gujarat Kidney and Super Speciality has raised Rs. 100.01 crore from 10 anchor investors on December 19. Company’s IPO will open for subscription on Dec 22. The comapny has finalised allocation of 87.73 lakh equity shares to anchor investors at upper price band. 

The Gujarat-based hospital chain is set to launch its IPO for the public on December 22, targetting to raise Rs 250.8 crore via initial share sale of 2.2 crore equity shares at the upper price band of Rs 108-114 per share. The offer consists of entirely fresh issue.

Craft Emerging Market Fund through its two sub funds – Citadel Capital Fund and Elite Capital Fund – is the largest investor in the company’s anchor book, acquiring 39.47 lakh shares for Rs 45 crore. This follows Khandelwal Finance and Venus Investments which picked up 13.16 lakh shares for Rs 15 crore, and 8.77 lakh shares for Rs 10 crore, respectively.

Nexus Global Opportunities Fund, Arnesta Global Opportunities Fund, Zeta Global Funds, Religo Commodities Ventures Trust, Sunrise Investment Trust, and Innovative Vision Fund were other investors in the anchor book, each buying 4.38 lakh shares for Rs 5 crore in Gujarat Kidney. Vadodara-based Gujarat Kidney and Super Speciality Limited is a multispecialist company providing healthcare services at several locations in Gujarat. The company is bringing an IPO on the NSE and BSE mainboard to meet its desired capital requirements for the proposed acquisition of Parekhs Hospital in Ahmedabad, partial payment of the purchase consideration for the already acquired “Ashwini Medical Center”, financing the company’s capital expenditure requirements for setting up a new hospital in Vadodara, purchase of robotics equipment for the Vadodara-based Gujarat Kidney and Super Speciality Hospital, full or partial repayment and/or prepayment of certain outstanding secured loans taken by the company, financing inorganic growth through unidentified acquisitions and general corporate purposes, and acquisition of additional shareholding in the Bharuch-based subsidiary “Harmony Medicare Private Limited”. The Business Remedies team has obtained information regarding the company’s business activities from the company’s prospectus.

Established in 2019, Gujarat Kidney and Super Speciality Limited (GKSL) specializes in providing multispeciality healthcare services at multiple locations in the state of Gujarat, India.

The company operates seven multispeciality hospitals and four pharmacies, with a total bed capacity of 490, an approved capacity of 455 beds, and an operational capacity of 340 beds.

The company’s hospitals include Gujarat Kidney and Super Speciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Pamland Hospital Private Limited (Bharuch), Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Center (Anand). The company also operates Ashwini Medical Store (Anand).

Gujarat Super Speciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma care, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology. As of June 30, 2025, the company employed 89 doctors, 332 nurses, and 338 other staff members.

Financial performance: In the financial year 2024, the company earned total revenue of Rs 5.48 crore and a profit after tax of Rs 1.71 crore, and in the financial year 2025, the company earned total revenue of Rs 40.40 crore and a profit after tax of Rs 9.50 crore. In the period ended June 30, 2025 of the financial year 2026, the company earned total revenue of Rs 15.27 crore and a profit after tax of Rs 5.40 crore. The financial results clearly indicate that the company’s revenue and profit are increasing year on year. In the period ended June 30, 2025 of the financial year 2026, the company achieved a profit after tax margin of 35.41 percent.

Information regarding the IPO: The IPO of Gujarat Kidney and Super Speciality Limited will open on December 22, 2025 and close on December 24, 2025, on the BSE and NSE mainboard. The company is issuing upto 2,20,00,000 shares of face value Rs 2 each. The IPO is being managed by the Book Running lead manager(BRLM) Nirbhay Capital Services Private Limited.

Business Tags:Business

Post navigation

Previous Post: Cranberries and Digestive Health: Supporting the Stomach and Gut from Within
Next Post: Hire Software Engineers with Ease – WeblineGlobal Revamps its Global Website

Related Posts

  • SFO Technologies and Cochin Shipyard jointly develops India’s First Indigenous Hybrid Laser Arc Welding Technology Business
  • Digital Twin: The Doorway to Smart Manufacturing Business
  • B20 and C2FO Collaborate on Solutions for Micro, Small and Medium-Sized Businesses Business
  • India Isn’t Catching Up to APAC’s Office Market. It’s Leading It. Business
  • Shyam Metalics Commissions Aluminium Foil Facility in Odisha, Invests around Rs. 800 crore; Aluminium FRP plant on Track for September Launch Business
  • First-Of-Its-Kind Corporate Banking Event Cbnxt’26 Unveils First Speaker Lineup Featuring Leaders From Yes Bank, HDFC Bank, Standard Chartered, HSBC, and More Business

Recent Posts

  • Fredna Dental Systems Partners with South Korea’s & Introduces BIOTEM AR Implant Technology in India
  • Make Your Financial Plans Easier with a Personal Loan
  • Gohil Group plans G-Farm retail outlets in Ahmedabad and Surat
  • P.C. Chandra Group’s 13th Edition of Jahar Lal Chandra Merit Scholarship Programme
  • Quest Alliance CEO Aakash Sethi Named to TIME100 Next: India, TIME’s Inaugural List of 100 Individuals Defining the Future of India

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • UniHealth Hospitals Limited Announces the Commissioning of its Advanced Tertiary Care, Multi-Specialty Hospital in Navi Mumbai Lifestyle
  • Launch of the Book ‘AI-ify Yourself’ at Sarla Birla University Lifestyle
  • Why Viral Roger’s Adventure Fantasy Novel: The Quests of William Wood – The Mysterious Elixir is a Must Read Lifestyle
  • Star-Studded Launch Marks the Grand Opening of NINJANOS – Mira Road’s New Multi-Cuisine Café Lifestyle
  • Antariksh Group founders C.A. L.V. Rathi and Bhagwanji N Patel bag honour at Economic Times ChangeMakers Lifestyle
  • LG announces its New seasons’ celebrationwith attractive offerson purchase of various products Business
  • India Drugged – An Eye Opener Business
  • Journey so far of a Privileged Artist Manager – Radhika Mistry Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme